Serine hydrolase RBBP9 (RBBP9)

About Serine hydrolase RBBP9

Serine hydrolase RBBP9 (RBBP9) is a protein from Homo sapiens identified by UniProt accession O75884, 186 residues long. MolForge cross-references it against 0 known binders and 20 disease associations.

Target properties

Protein name	Serine hydrolase RBBP9
UniProt accession	O75884
Gene	RBBP9
Organism	Homo sapiens
Length	186 residues
Molecular weight	—
EC numbers	—
Target class	UNCLASSIFIED
Subcellular location	—
Keywords	—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tier	MEDIUM
Druggability score	—
Pocket score	—
Max clinical phase	—

Approved drugs hitting this target (1)

DrugCentral-linked approved drugs that act on this protein.

Disease associations (20)

Diseases linked to this target (Open Targets).

hemoglobin measurement · score 0.03
DNA methylation · score 0.03
sleep measurement · score 0.03
hematocrit · score 0.02
neoplasm · score 0.02
cancer · score 0.01
head and neck squamous cell carcinoma · score 0.01
Fanconi anemia · score 0.01
pancreatic carcinoma · score 0.01
Friedreich ataxia · score 0.00

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

Structure	Source	Method	Mean pLDDT	Resolution (Å)
AF-O75884-F1	alphafold	PREDICTED	96.62	—

Amino-acid sequence (186 residues)

MASPSKAVIV PGNGGGDVTT HGWYGWVKKE LEKIPGFQCL AKNMPDPITA RESIWLPFME TELHCDEKTI IIGHSSGAIA AMRYAETHRV YAIVLVSAYT SDLGDENERA SGYFTRPWQW EKIKANCPYI VQFGSTDDPF LPWKEQQEVA DRLETKLHKF TDCGHFQNTE FHELITVVKS LLKVPA

External references

UniProt AlphaFold QuickGO RCSB PDB GeneCards